Treatment of Cognitive and Negative Symptoms in Schizophrenia With N-acetylcysteine
Clinical trial NCT02505477 · COMPLETED
Trial details
- NCT number
- NCT02505477
- Sponsor
- University of California, Los Angeles
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-06
- Primary completion
- 2023-01-31
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.